Inflammasomes in COPD and neutrophilic asthma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Thorax

• Publication date

  2015-10-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/thoraxjnl-2014-206736PMID 26493990
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ASC has extracellular and prionoid activities that propagate inflammation

  2014cited by this paper
• Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD

  2013cited by this paper
• A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis.

  2013cited by this paper
• Elevated expression of the NLRP3 inflammasome in neutrophilic asthma

  2013cited by this paper
• Inflammasome-regulated cytokines are critical mediators of acute lung injury.

  2012cited by this paper
• Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples.

  2011cited by this paper
• The inflammasomes.

  2010cited by this paper
• The role of interleukin-1beta in murine cigarette smoke-induced emphysema and small airway remodeling.

  2009cited by this paper

• The covert struggle: Tuberculosis amidst silicosis cases

  2025cites this paper
• Disulfiram alleviates epithelial barrier disruption in ozone-induced chronic obstructive pulmonary disease mouse models via inhibiting Gasdermin D-mediated pyroptosis.

  2025cites this paper
• Resveratrol as a naturally occurring inflammasome modulator: Implications for health and disease

  2025cites this paper
• NLRP3 Inflammasome Activation Modulates Neutrophil Extracellular Trap Formation and Aggravates Airway Inflammation in Bronchiectasis

  2025cites this paper
• Interaction, diagnosis, and treatment of lung microbiota-NLRP3 inflammasome-target organ axis in sepsis.

  2025cites this paper
• Inhibition of phosphoinositide 3-kinase activity attenuates neutrophilic airway inflammation and inhibits pyrin domain-containing 3 inflammasome activation in an ovalbumin-lipopolysaccharide-induced asthma murine model

  2024cites this paper
• Andrographolide Attenuates NLRP3 Inflammasome Activation and Airway Inflammation in Exacerbation of Chronic Obstructive Pulmonary Disease

  2024cites this paper
• Inhibitory Effect of P22077 on Airway Inflammation in Rats with COPD and Its Mechanism

  2024cites this paper
• New markers in chronic obstructive pulmonary disease.

  2024cites this paper
• Inhalable Saharan dust induces oxidative stress, NLRP3 inflammasome activation, and inflammatory cytokine release.

  2023cites this paper
• Pseudomonas-dominant Microbiome Elicits Sustained IL-1β Upregulation in Alveolar Macrophages from Lung Transplant Recipients.

  2023cites this paper
• AIM2 participates in house dust mite (HDM)-induced epithelial dysfunctions and ovalbumin (OVA)-induced allergic asthma in infant mice

  2023cites this paper
• Characterization and inhibition of inflammasome responses in severe and non-severe asthma

  2023cites this paper
• Glucocorticoids, Their Uses, Sexual Dimorphisms, and Diseases: New Concepts, Mechanisms, and Discoveries.

  2023cites this paper
• Mechanisms underlying corticosteroid resistance in patients with asthma: a review of current knowledge

  2023cites this paper
• Brain structural and functional alterations related to anxiety in allergic asthma.

  2023cites this paper
• Daphnetin ameliorates PM2.5-induced airway inflammation by inhibiting NLRP3 inflammasome-mediated pyroptosis in CS-exposed mice.

  2023cites this paper
• A Prospective Observational Study on Prescribing Pattern of Inhalers and Evaluating the Adherence to Inhalational Technique in Patients with Obstructive Lung Disease – Pilot Study

  2023cites this paper
• Phenotype overlap in the natural history of asthma

  2023cites this paper
• Symptomatology and microbiology of the gastrointestinal tract in post‐COVID conditions

  2022cites this paper
• Pyroptosis and respiratory diseases: A review of current knowledge

  2022cites this paper
• Understanding the pathogenesis of occupational coal and silica dust-associated lung disease

  2022cites this paper
• Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma

  2022cites this paper
• Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β

  2022cites this paper
• Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury

  2022cites this paper
• Yifei Sanjie Formula Treats Chronic Obstructive Pulmonary Disease by Remodeling Pulmonary Microbiota

  2022cites this paper
• Blockade of NLRP3/Caspase-1/IL-1β Regulated Th17/Treg Immune Imbalance and Attenuated the Neutrophilic Airway Inflammation in an Ovalbumin-Induced Murine Model of Asthma

  2022cites this paper
• Involvement of NLRP3/Caspase-1/GSDMD-Dependent Pyroptosis in BPA-Induced Apoptosis of Human Neuroblastoma Cells.

  2022cites this paper
• Pseudomonas aeruginosa Elicits Sustained IL-1β Upregulation in Alveolar Macrophages from Lung Transplant Recipients

  2022cites this paper
• Emerging Insights into the Impact of Air Pollution on Immune-Mediated Asthma Pathogenesis

  2022cites this paper
• IL-17A Mediates Pyroptosis via ERK Pathway and Contributes to Steroid Resistance in CRSwNP.

  2022cites this paper
• Aim2 suppresses cigarette smoke‐induced neutrophil recruitment, neutrophil caspase‐1 activation and anti‐Ly6G‐mediated neutrophil depletion

  2022cites this paper
• Chronic Obstructive Pulmonary Disease COPD and lung cancer: is the inflammasome at the cross talk?

  2022cites this paper
• Intranasal curcumin and dexamethasone combination ameliorates inflammasome (NLRP3) activation in lipopolysachharide exposed asthma exacerbations.

  2022cites this paper
• Nutraceuticals with anti-inflammatory and anti-oxidant properties as intervention for reducing the health effects of fine particulate matter: Potential and Prospects.

  2021cites this paper
• Microbiome Links Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease and Dietary Fiber via the Gut-Lung Axis: A Narrative Review

  2021cites this paper
• Which Therapy for Non-Type(T)2/T2-Low Asthma

  2021cites this paper
• Clinical features and mechanistic insights into drug repurposing for combating COVID-19

  2021cites this paper
• Eosinophilic Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma.

  2021cites this paper
• Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases.

  2021cites this paper
• Pyroptosis-induced inflammation and tissue damage.

  2021cites this paper
• Involvement of NLRP3/Caspase-1/GSDMD-Dependent Pyroptosis In BPA-Induced Apoptosis of Neuroblastoma Cells

  2021cites this paper
• Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases

  2021cites this paper
• The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention.

  2021cites this paper
• IL-1/IL-1R Signaling in Head and Neck Cancer

  2021cites this paper
• "Chemical modulation of gasdermin-mediated pyroptosis and therapeutic potential".

  2021cites this paper
• IL-1β augments TGF-β inducing epithelial-mesenchymal transition of epithelial cells and associates with poor pulmonary function improvement in neutrophilic asthmatics

  2021cites this paper
• Isoforskolin Alleviates AECOPD by Improving Pulmonary Function and Attenuating Inflammation Which Involves Downregulation of Th17/IL-17A and NF-κB/NLRP3

  2021cites this paper
• Time‐resolved proteomic profiling of cigarette smoke‐induced experimental chronic obstructive pulmonary disease

  2021cites this paper
• Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950

  2021cites this paper
• Leukotriene B4 Receptors Are Necessary for the Stimulation of NLRP3 Inflammasome and IL-1β Synthesis in Neutrophil-Dominant Asthmatic Airway Inflammation

  2021cites this paper
• microRNA‐22‐3p plays a protective role in a murine asthma model through the inhibition of the NLRP3–caspase‐1–IL‐1β axis

  2021cites this paper
• Systems Approaches to Treatment Response to Imatinib in Severe Asthma: A Pilot Study

  2021cites this paper
• Gu-Ben-Fang-Xiao decoction modulates lipid metabolism by activating the AMPK pathway in asthma remission.

  2021cites this paper
• Chitin induces steroid-resistant airway inflammation and airway hyperresponsiveness in mice.

  2021cites this paper
• Asthma-COPD overlap: current understanding and the utility of experimental models

  2021cites this paper
• New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy

  2020cites this paper
• MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome

  2020cites this paper
• Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease

  2020cites this paper
• Emerging therapeutic targets and preclinical models for severe asthma

  2020cites this paper
• Sanfu herbal patch applied at acupoints in patients with bronchial asthma: study protocol for a randomized controlled trial

  2020cites this paper
• The role of the microbiome and the NLRP3 inflammasome in the gut and lung

  2020cites this paper
• New drugs under development for COPD

  2020cites this paper
• Role of IL-17 and IL-23 in the Pathogenesis of Neutrophilic Asthma

  2020cites this paper
• Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases

  2020cites this paper
• Human β‐defensin‐2 suppresses key features of asthma in murine models of allergic airways disease

  2020cites this paper
• Emerging concepts and directed therapeutics for the management of asthma: regulating the regulators

  2020cites this paper
• Microbiome-focused asthma management strategies.

  2019cites this paper
• Asthma and/or hay fever as predictors of fertility/impaired fecundity in U.S. women: National Survey of Family Growth

  2019cites this paper
• Dexamethasone alleviate allergic airway inflammation in mice by inhibiting the activation of NLRP3 inflammasome.

  2019cites this paper
• Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke.

  2019cites this paper
• Cellular mechanisms underlying steroid-resistant asthma

  2019cites this paper
• Nickel-refining fumes induce NLRP3 activation dependent on mitochondrial damage and ROS production in Beas-2B cells.

  2019cites this paper
• Association of NLRP1 Coding Polymorphism with Lung Function and Serum IL-1β Concentration in Patients Diagnosed with Chronic Obstructive Pulmonary Disease (COPD)

  2019cites this paper
• Serum IL-1β can be a biomarker in children with severe persistent allergic rhinitis

  2019cites this paper
• Early Career Members at the Lung Science Conference and the Sleep and Breathing Conference 2019

  2019cites this paper
• Role of miRNA-181a-2-3p in cadmium-induced inflammatory responses of human bronchial epithelial cells.

  2019cites this paper
• NOD-like receptor family, pyrin domain containing 3 (NLRP3) contributes to inflammation, pyroptosis, and mucin production in human airway epithelium on rhinovirus infection.

  2019cites this paper
• Blockade of the NLRP3/Caspase-1 Axis Ameliorates Airway Neutrophilic Inflammation in a Toluene Diisocyanate-Induced Murine Asthma Model.

  2019cites this paper
• Functional effects of the microbiota in chronic respiratory disease.

  2019cites this paper
• Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects.

  2019cites this paper
• AIM2 Inflammasome Activation Leads to IL-1α and TGF-β Release From Exacerbated Chronic Obstructive Pulmonary Disease-Derived Peripheral Blood Mononuclear Cells

  2019cites this paper
• The Future of Asthma Care: Personalized Asthma Treatment.

  2019cites this paper
• Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs).

  2019cites this paper
• Lung development and emerging roles for type 2 immunity

  2019cites this paper
• Saturated fatty acids, obesity, and the nucleotide oligomerization domain–like receptor protein 3 (NLRP3) inflammasome in asthmatic patients

  2019cites this paper
• Airway Epithelium Dysfunction in Cystic Fibrosis and COPD

  2018cites this paper
• NLRP3 Inflammasome Involves in the Acute Exacerbation of Patients with Chronic Obstructive Pulmonary Disease

  2018cites this paper
• Nontypeable Haemophilus influenzae and chronic obstructive pulmonary disease: a review for clinicians

  2018cites this paper
• Targeting cytokines to treat asthma and chronic obstructive pulmonary disease

  2018cites this paper
• Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities

  2018cites this paper
• Molecular pathogenesis in chronic obstructive pulmonary disease and therapeutic potential by targeting AMP‐activated protein kinase

  2018cites this paper
• NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter.

  2018cites this paper
• Macrophages and neutrophils: dynamic duo or partners in crime?

  2018cites this paper
• Effects of Macrolide and Corticosteroid in Neutrophilic Asthma Mouse Model

  2017cites this paper
• Mitochondrial Dysfunction in Airway Disease

  2017cites this paper
• Role of the inflammasome in chronic obstructive pulmonary disease (COPD)

  2017cites this paper
• Microbiome effects on immunity, health and disease in the lung

  2017cites this paper
• Microbiomes in respiratory health and disease: An Asia‐Pacific perspective

  2017cites this paper